Research Article

Morbidity and Mortality of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: National Cancer Institute, Mexico City, Mexico

Table 2

Complications.

Complications9 cases (37%) 2 bleeding
1 pneumonia 1 Fístula
1 acute renal failure
4 diaphragm opening
15 no (%)

Reoperation 2 cases (8.33%)Bleeding into the operated site

Intensive care13 yes (54%)1 bleeding
5 extended surgery time
11 no (46%)4 diaphragm opening

Mortality0No